Puma Biotechnology | PBYI - Azione





Azione Cambiamento Data
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amgen USD 6.19B 39M 2026-03
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Daiichi Sankyo JPY 608.55B 93.64B 2025-09
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Exelixis USD 21.69M 5.71M 2025-12
Gilead Sciences USD 1.77B 11M 2025-12
Glaxosmithkline GBP 6.12B 46M 2025-09
Incyte USD 115.62M 14.56M 2026-03
MacroGenics USD 7.91M 840K 2025-12
Moderna USD 146M 7M 2026-03
Novartis USD 6.29B 17M 2026-03
Pfizer USD 10.67B 13M 2026-03
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Takeda JPY 1.41T 107.71B 2025-12
TG Therapeutics USD 125.59M 21.37M 2025-12
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
Vanda Pharmaceuticals USD 1.85M 190K 2025-12
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03